Clinical Trial Results TV
March 11, 2018: Dr. Brendan Everett and Dr. C. Michael Gibson Discuss: CANTOS - Anti-Inflammatory Therapy with Canakinumab and Incident
Dr. Brendan Everett and Dr. C. Michael Gibson Discuss: CANTOS - Anti-Inflammatory Therapy
with Canakinumab and Incident Type 2 Diabetes: A Pre-Specified Key Secondary Endpoint of
the CANTOS Trial

TBD

[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
05-20-2018 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted